Integrative Biological Analysis of the APOE*3-Leiden Transgenic Mouse

OMICS A Journal of Integrative Biology

Volumn 8, Issue 1, 2004, Pages 3-13

  Clish, Clary B ^a   Davidov, Eugene ^a   Oresic, Matej ^a   Plasterer, Thomas N ^a   Lavine, Gary ^a   Londo, Tom ^a   Meys, Michael ^a   Snell, Philip ^a   Stochaj, Wayne ^a   Adourian, Aram ^a   Zhang, Xiang ^a   Morel, Nicole ^a   Neumann, Eric ^a   Verheij, Elwin ^b   Vogels, Jack T W E ^b   Havekes, Louis M ^b,c   Afeyan, Noubar ^a   Regnier, Fred ^d   Van Der Greef, Jan ^a,b,e   Naylor, Stephen ^a,f  

^a Beyond Genomics   (United States)

^b TNO   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d PURDUE UNIVERSITY   (United States)

^e LEIDEN UNIVERSITY   (Netherlands)

^f Engineering Systems Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E3; DNA; FATTY ACID BINDING PROTEIN; LIPID; LIVER PROTEIN; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; FATTY ACID-BINDING PROTEINS; GENOME; HUMANS; LIPID METABOLISM; LIVER; LYSOPHOSPHATIDYLCHOLINES; MASS SPECTROMETRY; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRYPSIN;

ANIMALIA; MAMMALIA; MUS MUSCULUS;

EID: 11144355343     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/153623104773547453     Document Type: Article

References (32)

1. ASHBURNER, M., BALL, C.A., BLAKE, J.A., et al. (2000). Gene ontology tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25, 25-29.
2. BOORD, J.B., FAZIO, S., and LINTON, M.F. (2002). Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 13, 141-147.
3. BORCHERS, T., and SPENER, F. (1994). Fatty acid binding proteins. Curr Topics Membranes 40, 261-294.
4. BUTTE, A.J., TAMAYO, P., SLONIM, D., et al. (2000). Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. Proc Natl Acad Sci USA 97, 12182-12186.
5. CLAUDEL, T., STURM, E., DUEZ, H., et al. (2002). Bile acid-activated nuclear receptor FXR suppression apo AI transcription via a negative FXR response element. J Clin Invest 109, 961-971.
6. COIFMAN, R.R., and WICKERHAUSER, M.V. (1996). Wavelets, adapted waveform and de-noising. Electroencephalogr Clin Neurophysiol Suppl 45, 57-78.
7. DAVIDOV, E.J., HOLLAND, J., MARPLE, E.W., et al. (2003). Advancing drug discovery through systems biology. Drug Discov. Today 8, 175-183.
8. DAVIDSON, E.H., RAST, J.P., OLIVERI, P., et al. (2002) A genomic regulatory network for development. Science 295, 1669-1678.
9. GASPARI, M., VOGELS, J., WULFERT, F., et al. (2001) Novel strategies in mass spectrometric data handling. Adv Mass Spectr 15, 283-296.
10. GATLIN, C.L., KLEEMANN, G.R., HAYS, L.G., et al. (1998). Protein identification at the low femtamole level from silver-stained gels using a fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry. Anal Biochem 263, 93-101.
11. GATLIN, C.L., ENG, J.K., CROSS, S.T., et al. (2000). Automatedidentification of amino acid sequence variations in proteins by HPLC/microspray tandem mass spectrometry. Anal Chem 72, 757-763.
12. GLASS, C.K., and WITZTUM, J.L. (2001). Atherosclerosis, the road ahead. Cell 104, 503-516.
13. HAVEKES, L., DE WIT, E., LEUVEN, J.G., et al. (1986). Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum Genet 73, 157-163.
14. IDEKER, T., GALITSKI, T. and HOOD, L. (2001a). A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2, 343-372.
15. IDEKER, T., THORSSON, V., RANISH, J.A., et al. (2001b) Integrated genomic and proteomic analysis of a systematically perturbed metabolic network. Science 292, 929-934.
16. JONG, M.C., DAHLMANS, V.E., VAN GORP, P.J., et al. (1996). Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3 Leiden and human apolipoprotein C1. Arterioscler Thromb Vasc Biol 16, 934-940.
17. KERR, M.K., and CHURCHILL, G.A. (2001). Experimental design for gene expression microarrays. Biostatistics 2, 183-201.
18. KITANO, H. (2002). Systems biology: a brief overview. Science 295, 1662-1664.
19. KREEFT, A.J., MOEN, C.J., HOFKER, M.H., et al. (2001). Identification of differentially regulated genes in mildly hyperlipidemic ApoE3-Leiden mice by use of a serial analysis of gene expression. Arterioscler Thromb Vasc Biol 21, 1984-1990.
20. LINK, A.J., ENG, J., SCHIELTZ, D.M., et al. (1999). Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 17, 676-682.
21. LUTGENS, E., DAEMEN, M., KOCKX, M., et al. (1999). Atherosclerosis in APOE*3-Leiden transgenic mice. From proliferative to atheromatous stage. Circulation 99, 276-283.
22. MAKOWSKI, L., BOORD, J.B., MAEDA, K., et al. (2001). Lack of macrophage fatty-acid binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7, 699-705.
23. PACKARD, C.J., O'REILLY, D.S., CASLAKE, M.J., et al. (2000). Lipoproteins-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 343, 1148-1155.
24. PARK, Z.Y., and RUSSELL, D.H. (2000). Thermal denaturing: useful approach in peptide mass mapping. Anal Chem 72, 2667-2670.
25. PETERS, J.M., HENNUYER, N., STAELS, B., et al. (1997) Alterations in lipoprotein metabolism in PPAR-alpha deficient mice. J Biol Chem 272, 27307-27312.
26. SHESKIN, D.J. (2000). Handbook of Parametric and Nonparametric Statistical Procedures (Chapman & Hall/CRC, Boca Raton, FL).
27. STEVENS, J.P. (2002). Applied Multivariate Statistics for Social Sciences (Lawrence Erlbaum Associates, Mahwah, NJ).
28. VAN DEN MAAGDENBERG, A.M., DE KNIJFF, P., STALENHOEF, A.F., et al. (1989). Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4. Biochem Biophys Res Commun 165, 851-857.
29. VAN DEN MAAGDENBERG, A.M., HOFKER, M.H., KRIMPENFORT, P.J., et al. (1993). Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem 268, 10540-10545.
30. VU-DAC, N., CHOPIN-DELANNOY, S., GERVOIS, P., et al. (1998). The nuclear receptor PPA-alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J Biol Chem 273, 25713-25720.
31. WOLFRUM, C., BORRMANN, C.M., BORCHERS, T., et al. (2001). Fatty acids and hypolipidemic drugs regulat peroxisome proliferatot-activated receptors alpha- and gamma-mediated gene expression via liver fatty acid binding protein. Proc Natl Acad Sci USA 98, 2323-2328.
32. WASHBURN, M.P., WOLTERS, D., and YATES, J.R., III (2001). Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19, 242-247.